RCUS — ARCUS BIOSCIENCES INC

Ownership history in ALGERT GLOBAL LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in ARCUS BIOSCIENCES INC (RCUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.31% (2019 Q4)
Avg. % of fund
0.07%
First filed
2019 Q3
Last filed
2025 Q3
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 82,950 +5,294 +6.8% 0.02% $1.1M $13.60
2025 Q2 REDUCED 77,656 -191,376 -71.1% 0.01% $632K $8.14
2025 Q1 ADDED 269,032 +88,910 +49.4% 0.05% $2.1M $7.85
2024 Q4 ADDED 180,122 +67,275 +59.6% 0.06% $2.7M $14.89
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RCUS price (monthly, adj. close)

Other funds also holding RCUS

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 38.69% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.53% DAFNA Capital Management LLC 3Y 7Y 2.39% Parkman Healthcare Partners LLC 3Y 2.2% Siren, L.L.C. 2.14% Decheng Capital LLC 1.74% First Turn Management, LLC 1.54% Logos Global Management LP 3Y 1.51% Knott David M Jr 3Y 1.34% Sofinnova Investments, Inc. 3Y 7Y 1.13%
← Back to ALGERT GLOBAL LLC Holdings